Instrument Inactif

Communiqués Alta Natural Herbs & Supplements Ltd Toronto S.E.

Actions

Genix Announces TSX-V Approval of Warrant Amendments	06/02	NE
Genix Announces Warrant Repricing and Seeks Extension	19/01	NE
Genix Pharmaceuticals : Announces Auditor Resignation	14/11/22	PU
Genix Proposes to Extend Warrants	21/07/22	AQ
Genix Pharmaceuticals : MD&A ending April 30, 2022	29/06/22	PU
Genix Pharmaceuticals : - Form of Proxy	27/04/22	PU
Genix Pharmaceuticals : - Notice and Information Circular	27/04/22	PU
Genix Pharmaceuticals Corp :oration Receives Natural Product Number for Rechlor from Health Canada	09/09/21	AQ
Genix Pharmaceuticals Corp. Receives Approval for Drug Establishment License	15/07/21	NE
Genix Pharmaceuticals Corp. Lists on the OTCQB Venture Market Exchange	21/06/21	NE
Genix Pharmaceuticals Corporation Provides a Corporate Update to Shareholders	07/06/21	NE
Genix Pharmaceuticals Corporation Enters into Exclusive License and Supply Agreement for Canada's First Generic Thyroid Medication	01/04/21	NE
Genix Pharmaceuticals Corporation Prepares to File Abbreviated New Drug Submissions (ANDS) for Its First Ten Ophthalmic Drugs with Health Canada	22/03/21	NE
Genix Pharmaceuticals Corporation Announces AGM Results and Welcomes New Director	22/09/20	NE

Aucun résultat pour cette recherche